Journal of Immunology Research / 2015 / Article / Tab 2 / Research Article
Correlation between Genetic Variations and Serum Level of Interleukin 28B with Virus Genotypes and Disease Progression in Chronic Hepatitis C Virus Infection Table 2 Genotypic distribution for IL-28B gene polymorphism when patient group (groups “1+2+3”) was compared to control group.
SNPs Genotype/allele distribution Healthy controls HCV patients OR (95% C.I.) valuers8105790 2.784 (2.340–3.311) 137.99 <0.0001 CC 16 (2.7%) 159 (23.4%) CT 233 (38.8%) 280 (41.3%) TT 351 (58.5%) 239 (35.3%) C 265 (22.1%) 598 (44.1%) T 935 (77.9%) 758 (55.9%) CC + CT versus TT 2.589 (2.065–3.247) 69.23 <0.0001 CC versus CT + TT 0.089 (0.053–0.152) 116.35 <0.0001 rs8099917 2.552 (2.062–3.160) 77.16 <0.0001 GG 14 (2.3%) 104 (15.3%) GT 114 (19.0%) 138 (20.4%) TT 472 (78.7%) 436 (64.3%) G 142 (11.8%) 346 (25.5%) T 1058 (88.2%) 1010 (74.5%) GG + GT versus TT 2.047 (1.593–2.630) 31.91 <0.0001 GG versus GT + TT 0.132 (0.075–0.233) 64.25 <0.0001 rs7248668 1.863 (1.533–2.264) 39.72 <0.0001 AA 58 (9.7%) 94 (13.9%) AG 79 (13.2%) 172 (25.4%) GG 463 (77.2%) 412 (60.7%) A 195 (16.3%) 360 (26.5%) G 1005 (83.8%) 996 (73.5%) AA + AG versus GG 2.182 (1.708–2.788) 39.65 <0.0001 AA versus AG + GG 0.665 (0.470–0.941) 5.35 0.0206 rs12979860 1.476 (1.250–1.743) 21.15 <0.0001 TT 59 (9.9%) 73 (10.8%) CT 230 (38.6%) 367 (54.1%) CC 307 (51.5%) 238 (35.1%) T 348 (29.2%) 513 (37.8%) C 844 (70.8%) 843 (62.2%) TT + CT versus CC 1.964 (1.568–2.460) 34.88 <0.0001 TT versus CT + CC 0.911 (0.634–1.308) 0.26 0.61213 rs12980275 1.765 (1.488–2.093) 42.97 <0.0001 GG 59 (9.8%) 89 (13.12%) AG 184 (30.7%) 327 (48.2%) AA 357 (59.5%) 262 (38.6%) G 302 (25.2%) 505 (37.2%) A 898 (74.8%) 851 (62.8%) GG + AG versus AA 2.333 (1.863–2.920) 55.44 <0.0001 GG versus AG + AA 0.722 (0.509–1.023) 3.37 0.06631
Risk allele marked in BOLD letter.